Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 7:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 171 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Postprandial Glucose Clear all

Conditions: Postprandial Glycemic Response, Postprandial Hyperglycemia, Postprandial Insulin
Interventions: Stair Stepping, No exercise control; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: San Diego, California

Conditions: Diabetes Mellitus, Type 2
Interventions: Ultrasound Vagus Nerve Stimulation (DECIMA); Device
Lead sponsor: Aucta Technologies, Inc.; Industry
Eligibility: 21 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Type2 Diabetes
Interventions: Abbott Freestyle Libre Pro, LifeStyle; Device · Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 70 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes Mellitus, Type 2
Interventions: Weight reduction training, PPG training, discrete BG feedback, continuous BG feedback; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 21 Years to 80 Years
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Type 2 Diabetes
Interventions: Byetta (exenatide), Symlin (pramlintide); Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 12 Years to 21 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Diabetes Mellitus, Type 2
Interventions: premeal insulin lispro mixtures, insulin glargine, metformin; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 35 Years to 75 Years
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Impaired Glucose Tolerance
Interventions: Exenatide, Metformin; Drug
Lead sponsor: St. Paul Heart Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Saint Louis Park, Minnesota • Saint Paul, Minnesota

Conditions: Hyperinsulinemic Hypoglycemia
Interventions: Exenatide, Acarbose, Exenatide Placebo, Acarbose Placebo; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 60 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Normal Weight, Overweight and Obesity
Interventions: cinnamon; Dietary Supplement
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 20 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Metabolic Syndrome X, Atherosclerosis, Insulin Resistance, Hyperinsulinism, Glucose Metabolism Disorders, Metabolic Disease, Arteriosclerosis, Arterial Occlusive Diseases, Vascular Diseases, Cardiovascular Diseases
Interventions: Prolonged sitting without exercise, Prolonged sitting with interval exercise; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 40 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Metabolic Syndrome, Inflammation, Hypertriglyceridemia, Obesity
Interventions: Aronia berry juice, Sham comparator; Dietary Supplement · Other
Lead sponsor: Montana State University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Bozeman, Montana

Conditions: Pre-diabetes
Interventions: Sitagliptin, Placebo; Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 35 Years to 70 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Healthy Men
Interventions: 3.4 g psyllium, 6.8 g psyllium, Meal; Dietary Supplement · Other
Lead sponsor: Procter and Gamble; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Miamiville, Ohio

Conditions: Hyperglycemia, Cardiovascular Disease
Interventions: Green Tea Concentrate; Dietary Supplement
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 30 Years · Male only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Oxidative Stress
Interventions: Herbs and spices, High fat meal; Other
Lead sponsor: Penn State University; Other
Eligibility: 40 Years to 65 Years · Male only
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Type 2 Diabetes
Interventions: Extra Virgin Olive Oil, Refined Olive Oil; Other
Lead sponsor: Griffin Hospital; Other
Eligibility: 25 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Derby, Connecticut

Conditions: Postprandial Blood Glucose
Interventions: 1 minute of stair climbing and descending, 3 minute of stair climbing and descending, 10 minute of stair climbing and descending; Other
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: San Diego, California

Conditions: Diabetes, Gestational, Pregnancy Complications, Glucose Metabolism Disorders, Glucose Intolerance During Pregnancy
Interventions: Inhaled Technosphere Insulin; Drug
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 5
States / cities: Santa Barbara, California • Aurora, Colorado • New York, New York + 2 more

Conditions: Diabetes Mellitus, Type 2, PreDiabetes
Interventions: Dietary intervention; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Adiposity, Insulin Sensitivity, Impaired Glucose Tolerance, Metabolic Disturbance
Interventions: Hypercaloric, High Fat Diet; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 20 Years to 45 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Type 2 Diabetes Mellitus
Interventions: Exenatide, Glargine Insulin; Drug
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 1 Diabetes
Interventions: FCL+BPS, FCL; Device
Lead sponsor: Marc Breton; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Cardiovascular Disease
Interventions: Peanuts, Glucose and whipping cream, Oil Blend; Dietary Supplement
Lead sponsor: Penn State University; Other
Eligibility: 30 Years to 50 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Type 2 Diabetes Mellitus
Interventions: Exenatide SC, Exenatide IV, Placebo SC, Exendin-9, Placebo IV; Drug
Lead sponsor: Carl T. Hayden VA Medical Center; Federal
Eligibility: 35 Years to 70 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Phoenix, Arizona

Search by objective public record fields.

Short, Simple, Exercise to Improve Circadian Dependent Postprandial Glycemic Responses

Acute Study of Effect of Ultrasound Vagus Nerve Stimulation on Glycemia

Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes

Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification

The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes

The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes

Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia

Effect Cinnamon Spice on Postprandial Glucose and Insulin Responses

The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia

Impacts of Aronia on Inflammation and the Gut Microbiome

Incretins in Impaired Fasting Glucose

Study to Evaluate the Effects of Psyllium on Blood Glucose

Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction

The Acute Effect of Spices on Vascular Health

Post-prandial Effects of Extra Virgin Olive Oil on Endothelial Function in Adults at Risk for Type 2 Diabetes

Effect of Stair Climbing and Descending on Postprandial Blood Glucose

Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes

Prediabetes Stratification by Multi-omics Profile After Food Intake

Metabolic Adaptations to High-fat Diet

The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes

Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery

Effects of Peanut Consumption on Postprandial Inflammation, Glucose and Triglycerides

The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes